Stock-Based Compensation (Tables)

12 Months Ended

Oct. 03, 2020

Share-based Payment Arrangement, Noncash Expense [Abstract]

Schedule Of Summary Of Stock Options

	Shares Under Option	Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Life (in Years)	Aggregate Intrinsic Value (in millions)
Outstanding, September 28, 2019	5,362,672	$	54.03
Exercised	(661,549)	48.21
Forfeited or expired	(265,237)	76.06
Granted	1,515,587	90.04
Outstanding, October 3, 2020	5,951,473	$	62.86	6.8	$	37
Exercisable, October 3, 2020	3,231,765	$	50.96	5.4	$	37

Schedule Of Assumptions Of Fair Value Calculation Of Each Year's Grants

Assumptions used in the fair value calculation are as of the grant dates and are outlined in the following table.

	2020		2019		2018
Expected life (in years)	4.3		4.3		5.9
Risk-free interest rate	1.6	%	2.8	%	2.1	%
Expected volatility	25.7	%	25.4	%	23.5	%
Expected dividend yield	2.0	%	2.5	%	1.5	%

Schedule Of Summary Of Restricted Stock

	Number of Shares	Weighted Average Grant- Date Fair Value Per Share		Weighted Average Remaining Contractual Life (in Years)	Aggregate Intrinsic Value (in millions)
Nonvested, September 28, 2019	1,662,078	$	64.55
Granted	628,844	88.96
Dividends	44,704	74.51
Vested	(556,632)	60.30
Forfeited	(116,585)	74.18
Nonvested, October 3, 2020	1,662,409	$	74.79	1.3	$	99

Schedule Of Summary Of Performance-Based Shares

The following table summarizes the performance-based shares at the maximum award amounts based upon the respective performance share agreements. Actual shares that will vest depend on the level of attainment of the performance-based criteria.

	Number of Shares	Weighted Average Grant- Date Fair Value Per Share		Weighted Average Remaining Contractual Life (in Years)	Aggregate Intrinsic Value (in millions)
Nonvested, September 28, 2019	2,027,059	$	51.03
Granted	726,388	67.55
Vested	(344,870)	46.29
Forfeited	(445,440)	52.59
Nonvested, October 3, 2020	1,963,137	$	57.62	1.2	$	116